ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 999

Utility of Neutrophil CD64 Expression & sTREM-1 in Distinguishing Bacterial Infection from Disease Flare in SLE and ANCA Associated Vasculitis

Sajal Ajmani, Harshit Singh, Saurabh Chaturvedi, Mohit kumar Rai and Vikas Agrawal, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, Biomarkers, infection and vasculitis, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Infection-related Rheumatic Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Fever is a common presenting manifestation of systemic lupus erythematosus (SLE) and ANCA associated vasculitis (AAV). Treating physician is challenged to differentiate between disease activity vs. infection as to the cause of fever. Presently, there is no clinical or serological biomarker that may reliably differentiate between these two. We aimed to determine the usefulness of   CD64 (FcγR1) glycoprotein expression on the surface of neutrophils and sTREM-1 (soluble triggering receptor expressed on myeloid cells) levels in serum in distinguishing bacterial infection from disease flare in SLE and AAV patients

Methods: In this descriptive, cross sectional, observational study 20 healthy control and adult patients of SLE and AAV admitted to our unit either with disease flare or bacterial infection were recruited over a period of 1 year. Neutrophil CD64 expression was measured by flowcytometry and sTREM by ELISA from blood samples collected on the day of admission. Other parameters such as Total Leukocyte Count (TLC), erythrocyte sedimentation rate (ESR), C-Reactive Protein (CRP), C3, and C4 were noted.

Results: Among the 45 patients included in the study 29 (SLE-18 and AAV-11) had disease flare while 16 (SLE-12 and AAV-4) had infection. 62% had fever at presentation. Percentage of neutrophil with CD64 expression and their mean fluorescence intensity in patients with infection were significantly (p<0.05) higher as compared to those without infection and healthy controls (Table-1). CD64 expression as a marker for differentiation between disease flare and infection had a sensitivity of 94% and specificity of 88% at cut off of 30% (percentage of neutrophil expressing CD64). In contrast to CD64 expression on neutrophils, serum sTREM-1 level was not significantly different in patients with disease flare when compared to patients with infection. Though, CRP was significantly higher in patients with infection compared to those with disease flare (p<0.05), however, sensitivity and specificity of CRP to differentiate disease flare with infection was 53% and 79% respectively. TLC, ESR, C3, C4 levels were not significantly different between disease flare and infection group. On subgroup (Table-2) analysis patients of SLE with infection had a higher CRP and TLC compared those with disease flare (p<0.5). Sensitivity and specificity of TLC to differentiate SLE disease flare with infection was 54% and 77% respectively.

Conclusion: CD64 expression on neutrophils is helpful in differentiating bacterial infection from disease flare in patients with SLE and AAV.


Disclosure: S. Ajmani, None; H. Singh, None; S. Chaturvedi, None; M. K. Rai, None; V. Agrawal, None.

To cite this abstract in AMA style:

Ajmani S, Singh H, Chaturvedi S, Rai MK, Agrawal V. Utility of Neutrophil CD64 Expression & sTREM-1 in Distinguishing Bacterial Infection from Disease Flare in SLE and ANCA Associated Vasculitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/utility-of-neutrophil-cd64-expression-strem-1-in-distinguishing-bacterial-infection-from-disease-flare-in-sle-and-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-neutrophil-cd64-expression-strem-1-in-distinguishing-bacterial-infection-from-disease-flare-in-sle-and-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology